For the industry, the reclassification would allow them to make federal tax deductions that are currently prohibited for businesses involved in the sale of Schedule I or II drugs. Because of this prohibition, the cannabis industry has faced a significantly higher effective tax rate, and state governments have taken it upon themselves to provide state-level tax relief for their regulated markets.“While HHS’s scientific and medical evaluation is binding on DEA, the scheduling recommendation is not,” the HHS spokesperson said. “DEA has the final authority to schedule a drug under the [Controlled Substances Act] (or transfer a controlled substance between schedules or remove such a drug from scheduling altogether) after considering the relevant statutory and regulatory criteria and HHS’ scientific and medical evaluation. [Top Federal Health Agency Says Marijuana Should Be Moved To Schedule III In Historic Recommendation To DEA]
The bipartisan, bicameral bill would align DEA & FDA policy to increase access to research and limited medical use of psychedelic-assisted therapy. These innovative, groundbreaking therapies will help veterans & patients struggling with PTSD and treatment-resistant depression.
— The Daschle Group (@DaschleGroup) June 23, 2023
No comments:
Post a Comment
Republican is simply another word for Earth hater but comments intended to troll the author or other readers will not be published so use a handle or even your real name and don’t be an asshole.